Inventor

SPIELMANN HANS PETER

US20 patents

⚠️ This page may combine multiple inventors who share the name “SPIELMANN HANS PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPIELMANN HANS PETER

CERUS CORP

Method for photodecontamination of pathogens in blood using 5&#39;-primary aminopsoralens

Compounds for the photodecontamination of pathogens in blood

5′-primary aminoalkyl psoralen compositions with platelets

Methods for photodecontamination of pathogens in blood

4&#39;-primary aminopsoralen and platelet compositions

Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens

5&#39;-(4-amino-2-oxa)butye-4,4&#39;, 8-trinethylpsoralen in synthetic medium

Compounds for the photo decontamination of pathogens in blood

Synthesizing psoralen compounds useful as intermediates

Compounds for the photodecontamination of pathogens in blood

Psoralen compounds

Method for inactivation of pathogens in platelets using 4&#39; and 5&#39; primary amino-substituted psoralens

Method for the photo-decontamination of pathogens in blood using 4&#39;-primary amino psoralens

STERITECH INC

Compounds for the photodecontamination of pathogens in blood

Compounds for the photo-decontamination of pathogens in blood

Compounds for the photodecontamination of pathogens in blood

Compounds for the photodecontamination of pathogens in blood

UNIV KENTUCKY RES FOUND

Antibodies and unnatural substrates of prenylation enzymes for use in detecting and isolating prenylated proteins

Farnesyl pyrophosphate analogs

Tetrafluoroazidoaniline and method of making and using the same

Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens

4'-primary aminopsoralen and platelet compositions

5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium

Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens

Method for the photo-decontamination of pathogens in blood using 4'-primary amino psoralens